ORCL

Oracle Corporation

NYQ · Technology

$139.54

-$5.02 (-3.47%)down -3.47%

24 September 2026 · delayed 15+ min

F

Quality score50.0 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Oracle Corporation earns a F on excellent profit margins (>20%) and strong ROE (>20%) but high debt-to-equity ratio (>2.0) and negative free cash flow. Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 2.8% · $280.00 IQInvest estimate
Adjusted for Medium-term investors 2.8% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-ORCL-20260924engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

Lowest analyst target

$110.00

52-week low

$114.50

Today's price

$139.54

Mean analyst target

$237.97

52-week high

$322.54

Highest analyst target

$400.00

ORCL trades 12% of the way up its 52-week range, between $114.50 and $322.54. The mean analyst target of $237.97 is 70.5% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Strong ROE (>20%); High debt-to-equity ratio (>2.0); Negative free cash flow 90.023%

Profit margin

26.36%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

35.63%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

63.96%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

41.19%

Profit per unit of shareholder capital

very strongWhat this means

Profit generated per unit of shareholder capital.

Rare when sustained — check whether debt is flattering it, since borrowing shrinks the equity denominator.

Return on assets

6.36%

Profit per unit of assets

strongWhat this means

Profit generated per unit of everything the company owns.

The assets are working hard.

Debt to equity

251.72

Borrowings against equity

heavily gearedWhat this means

Borrowings measured against shareholder capital.

Debt magnifies both good years and bad, and raises the stakes when rates rise.

Current ratio

1.17

Short-term assets over short-term debts

adequateWhat this means

Short-term assets against short-term obligations.

Enough to cover near-term bills.

Quick ratio

1.02

As above, excluding inventory

comfortableWhat this means

Short-term assets excluding inventory, against short-term debts.

Liquid assets exceed short-term obligations.

Revenue growth

29.60%

Year on year

fast-growingWhat this means

Change in revenue against the same period last year.

Rapid growth, though the question is always how long it can hold.

Earnings growth

54.50%

Year on year

very strongWhat this means

Change in earnings against the same period last year.

Check whether it is repeatable or a one-off — a single asset sale can flatter this badly.

Revenue

$19.34B

Trailing twelve months

Free cash flow

$-45.85B

Cash left after capital spending

Operating cash flow

$46.94B

Cash from the business itself

Payout ratio

31.35%

Dividends as a share of earnings

conservativeWhat this means

The share of earnings paid out as dividends.

Comfortably covered, with room to keep raising it.

Growth & momentumPoor 1-year return (-54.2%); Low Sharpe ratio (0.39) 0.022%

Return, 1 month

-6.27%

Return, 3 months

-5.73%

Return, 6 months

-1.61%

Return, year to date

-28.01%

Return, 1 year

-54.25%

Return, 3 years

28.07%

Sharpe ratio

0.39

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

51.32%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

0.08%

Best day

35.95%

Worst day

-13.79%

ValuationAttractive PEG ratio (0.81); High P/B ratio (6.83) 70.018%

P/E ratio

21.87

Price against trailing earnings

moderateWhat this means

You pay 21.87 for every 1 unit of annual earnings.

Roughly the long-run market average band.

Forward P/E

12.69

Price against forecast earnings

lowWhat this means

Price against next year's *forecast* earnings.

The market expects little growth, or doubts the forecast.

PEG ratio

0.81

P/E adjusted for growth

cheap for the growthWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Under 1 is the classic Peter Lynch marker for growth you are not paying full price for.

Price to book

6.83

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

5.88

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

16.25

Whole-company value against cash earnings

highWhat this means

Whole-company value, debt included, against cash earnings.

Expensive even before interest, tax and depreciation are considered.

Enterprise value

$559.38B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

3,023,736,000

Shares the profit is split across

Dividend yield

1.38%

Annual dividend against price

modestWhat this means

Annual dividend as a percentage of the share price.

A small income component.

TechnicalRSI in healthy range (30-70); Price well below 200-day SMA (downtrend); MACD bearish (negative histogram) 45.015%

RSI (14)

42.5

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

-0.48

Momentum against its own trend

MACD histogram

-1.21

Positive is bullish

ADX

14.0

Trend strength; above 25 is a real trend

no clear trendWhat this means

Trend strength, regardless of direction.

Below about 20 the price is ranging rather than trending.

20-day average

$149.38

50-day average

$141.99

200-day average

$164.22

Price vs 50-day

-1.72%

Price vs 200-day

-15.03%

Bollinger upper

$162.02

Bollinger lower

$136.73

Average true range

7.34

Typical daily trading range

Stochastic %K

16.3

RiskHigh volatility risk; High beta (1.73) - more volatile than market 0.012%

Volatility, annualised

43.87%

How far it swings in a year

turbulentWhat this means

How far the price typically swings over a year.

Large swings in both directions — position size matters more than usual here.

Beta

1.73

Moves against the wider market

more volatile than the marketWhat this means

How much the price moves relative to the wider market.

Amplifies the index — bigger gains, bigger falls.

Maximum drawdown

-64.58%

Worst peak-to-trough fall

severeWhat this means

The worst peak-to-trough fall in the period measured.

A fall this deep needs roughly a doubling to recover.

Risk category

Very High

The engine's own banding

Analyst viewAnalyst consensus: Buy; Significant upside potential (70.5%) 100.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

41

Mean price target

$237.97

Highest target

$400.00

Lowest target

$110.00

Implied upside

70.54%

Target against today's price

largeWhat this means

How far the mean analyst target sits above today's price.

A wide gap, which as often means the price has fallen as that the target is right.

Price against the S&P 500

180 trading days to 2026-09-24

ORCL is 26.9% down over the window, against 11.3% up for the S&P 500 — behind by 38.3 points.
ORCL -26.9%S&P 500 +11.3%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2026-01-07, so they can be compared directly.
DateCloseORCL rebasedS&P 500 rebased
2026-01-07$191.00100.0100.0
2026-01-29$167.8487.9100.7
2026-02-20$147.0577.099.8
2026-03-13$154.0380.695.8
2026-04-06$144.5375.795.5
2026-04-27$172.3690.2103.7
2026-05-18$185.9697.4107.0
2026-06-09$205.10107.4106.7
2026-07-01$142.0174.3108.1
2026-07-23$120.0462.8107.0
2026-08-13$156.2281.8112.7
2026-09-03$154.0480.7111.9

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health90.023%20.7
Growth & momentum0.022%0.0
Valuation70.018%12.6
Technical45.015%6.8
Risk0.012%0.0
Analyst view100.010%10.0
ESG50.00%0.0
Quality score100%50.0

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

What each model believes. Pick one above, or set your own sliders below.
ModelThe emphasis
IQInvest defaultThe engine's own weighting: financial health 23% and performance 22% lead, valuation 18%, then technicals, risk and analysts.
Value investorPrice against worth dominates: valuation 40%, financial health 25%. Chart signals count for almost nothing.
Growth investorMomentum first: performance 40% and technicals 20%. Whether the price is fair today gets just 5%.
Sleep at nightStability over everything: risk 35% and financial health 30% together outweigh all other categories combined.
ChartistThe tape over the fundamentals: technicals 45% and performance 25%. Valuation is nearly ignored.
18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

F

50.0 / 100

Identical to the IQInvest grade.

All 66 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Shares outstandingValuation3,023,736,000Yahoo Finance
Price to salesValuation5.88Yahoo Finance
Price to bookValuation6.83Yahoo Finance
PEG ratioValuation0.81Yahoo Finance
P/E ratioValuation21.87Yahoo Finance
Forward P/EValuation12.69Yahoo Finance
EV / EBITDAValuation16.25Yahoo Finance
Enterprise valueValuation$559.38BYahoo Finance
Dividend yieldValuation1.38%Yahoo Finance
Stochastic %KTechnical16.3Yahoo Finance
RSI (14)Technical42.5Yahoo Finance
Price vs 50-dayTechnical-1.72%Yahoo Finance
Price vs 200-dayTechnical-15.03%Yahoo Finance
MACD histogramTechnical-1.21Yahoo Finance
MACDTechnical-0.48Yahoo Finance
Bollinger upperTechnical$162.02Yahoo Finance
Bollinger lowerTechnical$136.73Yahoo Finance
Average true rangeTechnical7.34Yahoo Finance
ADXTechnical14.0Yahoo Finance
50-day averageTechnical$141.99Yahoo Finance
200-day averageTechnical$164.22Yahoo Finance
20-day averageTechnical$149.38Yahoo Finance
Volatility, annualisedRisk43.87%Yahoo Finance
Risk categoryRiskVery HighYahoo Finance
Maximum drawdownRisk-64.58%Yahoo Finance
BetaRisk1.73Yahoo Finance
VolumeMarket data56,326,792Yahoo Finance
Previous closeMarket data$144.56Yahoo Finance
OpenMarket data$137.32Yahoo Finance
EmployeesMarket data141,000Yahoo Finance
Day lowMarket data$133.48Yahoo Finance
Day highMarket data$140.34Yahoo Finance
Average volumeMarket data32,975,398Yahoo Finance
52-week lowMarket data$114.50Yahoo Finance
52-week highMarket data$322.54Yahoo Finance
Worst dayGrowth & momentum-13.79%Yahoo Finance
Win rateGrowth & momentum51.32%Yahoo Finance
Sharpe ratioGrowth & momentum0.39Yahoo Finance
Return, year to dateGrowth & momentum-28.01%Yahoo Finance
Return, 6 monthsGrowth & momentum-1.61%Yahoo Finance
Return, 3 yearsGrowth & momentum28.07%Yahoo Finance
Return, 3 monthsGrowth & momentum-5.73%Yahoo Finance
Return, 1 yearGrowth & momentum-54.25%Yahoo Finance
Return, 1 monthGrowth & momentum-6.27%Yahoo Finance
Best dayGrowth & momentum35.95%Yahoo Finance
Average daily returnGrowth & momentum0.08%Yahoo Finance
Revenue growthFinancial health29.60%Yahoo Finance
RevenueFinancial health$19.34BYahoo Finance
Return on equityFinancial health41.19%Yahoo Finance
Return on assetsFinancial health6.36%Yahoo Finance
Quick ratioFinancial health1.02Yahoo Finance
Profit marginFinancial health26.36%Yahoo Finance
Payout ratioFinancial health31.35%Yahoo Finance
Operating marginFinancial health35.63%Yahoo Finance
Operating cash flowFinancial health$46.94BYahoo Finance
Gross marginFinancial health63.96%Yahoo Finance
Free cash flowFinancial health$-45.85BYahoo Finance
Earnings growthFinancial health54.50%Yahoo Finance
Debt to equityFinancial health251.72Yahoo Finance
Current ratioFinancial health1.17Yahoo Finance
Mean price targetAnalyst view$237.97Yahoo Finance
Lowest targetAnalyst view$110.00Yahoo Finance
Implied upsideAnalyst view70.54%Yahoo Finance
Highest targetAnalyst view$400.00Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Analysts coveringAnalyst view41Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more